Trauma market rebounds as top segments drive growth amid easy YoY comps
The Trauma Market experienced another quarter of healthy growth as the WW and US Trauma Markets ended Q221 up YoY compared to Q220. Looking forward to Q321, SmartTRAK feels that trauma procedures will likely not be as heavily impacted by the rise in the Delta variant as its elective procedure counterparts. We will continue to monitor the situation as the variant impacts states, as recently observed in Texas.
Among the many topics covered in detail in our comprehensive Q221 Trauma Market Recap* are: